应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
RNAM Avidity Biosciences, Inc.
停牌 02-27 11:42:55 EST
72.82
+0.00
0.00%
最高
72.82
最低
72.82
成交量
3.00
今开
72.82
昨收
72.82
日振幅
0.00%
总市值
112.68亿
流通市值
96.12亿
总股本
1.55亿
成交额
218.58
换手率
0.00%
流通股本
1.32亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
暂无数据
公司概况
公司名称:
Avidity Biosciences, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Avidity Biosciences, Inc.于2012年11月13日根据美国特拉华州法律成立。该公司致力于开发一类新的RNA疗法,称为抗体寡核苷酸偶联物(AOC)。其专有的AOC平台将单克隆抗体的特异性与RNA疗法的精确度相结合,以靶向以前无法治愈的疾病。Avidity的管道包括三个临床开发项目:用于Duchenne肌营养不良症的delpacibart zotadirsen、用于1型强直性营养不良症的delpacibart etedesiran和用于面肩肱型肌营养不良症的delpacibart braxlosiran。所有这些研究性疗法都获得了监管机构的孤儿认定和快速通道状态。2025年11月,Avidity宣布了其在美国的del-zota管理访问计划,通过授权的治疗方案为符合条件的患者提供访问权限。
发行价格:
--
{"stockData":{"symbol":"RNAM","market":"US","secType":"STK","nameCN":"Avidity Biosciences, Inc.","latestPrice":72.82,"timestamp":1772210575681,"preClose":72.82,"halted":3,"volume":3,"delay":0,"changeRate":0,"floatShares":132000000,"shares":154740172,"eps":-4.971541,"marketStatus":"停牌","change":0,"latestTime":"02-27 11:42:55 EST","open":72.82,"high":72.82,"low":72.82,"amount":218.58,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-4.971541,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1772442000000},"marketStatusCode":7,"adr":0,"listingDate":1591934400000,"exchange":"NASDAQ","adjPreClose":72.82,"volumeRatio":3.2544772765854853e-7,"impliedVol":0.0877,"impliedVolPercentile":0.5},"requestUrl":"/m/hq/s/RNAM/tweets","defaultTab":"tweets","newsList":[],"profile":{"websiteUrl":"http://www.aviditybiosciences.com;aviditybiosciences.investorroom.com","stockEarnings":[{"period":"1week","weight":-0.0005},{"period":"1month","weight":0.005},{"period":"3month","weight":0.0156},{"period":"6month","weight":0.5633},{"period":"1year","weight":1.5041},{"period":"ytd","weight":0.0096}],"compareEarnings":[{"period":"1week","weight":-0.005},{"period":"1month","weight":-0.0136},{"period":"3month","weight":0.0038},{"period":"6month","weight":0.0635},{"period":"1year","weight":0.1725},{"period":"ytd","weight":0.006}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Avidity Biosciences, Inc.于2012年11月13日根据美国特拉华州法律成立。该公司致力于开发一类新的RNA疗法,称为抗体寡核苷酸偶联物(AOC)。其专有的AOC平台将单克隆抗体的特异性与RNA疗法的精确度相结合,以靶向以前无法治愈的疾病。Avidity的管道包括三个临床开发项目:用于Duchenne肌营养不良症的delpacibart zotadirsen、用于1型强直性营养不良症的delpacibart etedesiran和用于面肩肱型肌营养不良症的delpacibart braxlosiran。所有这些研究性疗法都获得了监管机构的孤儿认定和快速通道状态。2025年11月,Avidity宣布了其在美国的del-zota管理访问计划,通过授权的治疗方案为符合条件的患者提供访问权限。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.025613},{"month":2,"riseRate":0.666667,"avgChangeRate":0.084219},{"month":3,"riseRate":0.4,"avgChangeRate":-0.00029},{"month":4,"riseRate":0.4,"avgChangeRate":-0.058331},{"month":5,"riseRate":0.4,"avgChangeRate":-0.018927},{"month":6,"riseRate":0.8,"avgChangeRate":0.113151},{"month":7,"riseRate":0.5,"avgChangeRate":0.027674},{"month":8,"riseRate":0.666667,"avgChangeRate":0.073003},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.048121},{"month":10,"riseRate":0.166667,"avgChangeRate":-0.000506},{"month":11,"riseRate":0.666667,"avgChangeRate":0.096576},{"month":12,"riseRate":0.666667,"avgChangeRate":0.110632}],"exchange":"NASDAQ","name":"Avidity Biosciences, Inc.","nameEN":"Avidity Biosciences, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Avidity Biosciences, Inc.(RNAM)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Avidity Biosciences, Inc.(RNAM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Avidity Biosciences, Inc.,RNAM,Avidity Biosciences, Inc.股票,Avidity Biosciences, Inc.股票老虎,Avidity Biosciences, Inc.股票老虎国际,Avidity Biosciences, Inc.行情,Avidity Biosciences, Inc.股票行情,Avidity Biosciences, Inc.股价,Avidity Biosciences, Inc.股市,Avidity Biosciences, Inc.股票价格,Avidity Biosciences, Inc.股票交易,Avidity Biosciences, Inc.股票购买,Avidity Biosciences, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Avidity Biosciences, Inc.(RNAM)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Avidity Biosciences, Inc.(RNAM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}